Skip to main content

Exploring the Viral Capsid Development Market: Detailed Insights on Size, Share, Growth Potential

 The global viral capsid development market size is anticipated to reach USD 684.5 million by 2033 and is projected to grow at a CAGR of 10.36% from 2026 to 2033, according to a new report by Grand View Research, Inc. The global viral capsid development industry is expanding as pharmaceutical companies, biotechnology firms, and research institutions increasingly adopt capsid-based solutions to support advanced gene therapy, vaccine development, and targeted drug delivery. The growing need to enhance therapeutic efficacy, improve vector stability, and accelerate clinical development is driving this growth, with viral capsid technologies gradually supplementing traditional biologics and delivery systems.

Advancements in capsid engineering, protein design, and vector formulation methods have created greater demand for viral capsids that offer improved targeting, reduced immunogenicity, and enhanced functional performance. Innovations such as engineered multi-serotype capsids, self-assembling nanoparticles, and bio-orthogonal modification strategies are enabling more consistent transduction efficiency, safer delivery, and broader applications across gene therapy, oncology, and vaccine platforms.

Download a free sample copy of the Viral Capsid Development Market report to understand detailed coverage and inclusions in the final report

The integration of viral capsid technologies with high-throughput screening, automation systems, and genomic analytics is improving development efficiency and supporting data-driven decision-making. These advancements allow developers to optimize capsid performance, enhance therapeutic outcomes, and achieve measurable clinical benefits in both preclinical research and commercial production.

Pharmaceutical developers, gene therapy companies, and academic research institutions will continue to rely on viral capsid solutions as these technologies help improve vector targeting, reduce off-target effects, and support scalable production. With rising global focus on personalized medicine, advanced therapeutics, and regulatory approval for next-generation biologics, viral capsid development is expected to remain essential for long-term innovation across healthcare and biotech sectors.

Looking for more specific insights? Customize this report to suite your business needs

Viral Capsid Development Market Report Highlights

  • By type, the adeno-associated virus (AAV) capsid segment led the market with the largest revenue share of 40.91% in 2025. Their strong ability to deliver genetic material efficiently, low immunogenicity, and broad applicability across multiple therapeutic areas continue to drive segment growth, supported by their widespread use in gene therapy and vaccine development.
  • By application, the gene therapy segment led the market with the largest revenue share of 44.87% in 2025. Increasing adoption of personalized medicine, rising demand for targeted therapeutic solutions, and growing need to improve treatment efficacy underpin this dominance, complemented by expanding use of viral capsids in rare disease and oncology treatments.
  • By end use, the pharmaceutical and biotechnology segment led the market with the largest revenue share of 50.83% in 2025. Growing focus on advanced therapeutic development, investment in next-generation biologics, and increasing awareness of long-term clinical benefits are accelerating demand, while integration with high-throughput screening and automation systems is further supporting efficient capsid development and application.

Explore Grand View Horizon to see global and regional level statistics related to the Viral Capsid Development Market

Viral Capsid Development Market Segmentation

Grand View Research has segmented the global viral capsid development market based on the type, application, end-use, and region:

Viral Capsid Development Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Adeno-associated Virus (AAV) Capsids
  • Adenoviral
  • Lentiviral
  • Others

Viral Capsid Development Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Gene Therapy
  • Vaccine Development
  • Cancer Therapy
  • Others

Viral Capsid Development End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institute
  • CROs & CMOs

Viral Capsid Development Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Explore our Interactive market dashboard to get a bird's-eye view of the Viral Capsid Development Market. Perform cross-segment analysis, look at market numbers pertaining to specific segments, geographies & timelines, and download these data points in image format that can be used in decks and presentations.

List of Key Players in the Viral Capsid Development Market

  • PackGene Biotech Inc.
  • Sartorius AG
  • Revvity
  • VectorBuilder
  • AAVnerGene
  • AskBio Inc.
  • Voyager Therapeutics
  • uniQure N.V.
  • Vigene Biosciences
  • Capsigen

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

  • Focused market intelligence reports on specific geographies or high-growth segments.
  • Extended forecast timelines for long-term planning.
  • Competitor Benchmarking and Supply Chain Analysis
  • Inclusion of regulatory and policy assessments.
  • Inclusion of custom data models, KPIs, or applications unique to your business
  • Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Comments

Popular posts from this blog

Welded Plate And Block Heat Exchanger Market Segments & Scope Analysis & Growth Forecast

  The global  welded plate and block heat exchanger market  size is anticipated to reach USD 1.2 billion by 2025, exhibiting a CAGR of 5.9% over the forecast period, according to a new report published by Grand View Research, Inc. The market is anticipated to be driven by the growing demand for the product in HVAC & refrigeration, power generation, and petrochemical industries, especially in emerging economies in Asia Pacific and CSA regions. Welded plate & block heat exchangers play a significant role in enhancing heat transfer efficiency of industrial machinery. Growing demand for efficient thermal management systems with low space requirements is expected to drive the demand for plate & block heat exchangers over the forecast period. Growth of industrial sectors including food & beverages, chemicals, pulp & paper, power generation, metal & mining, textiles, and oil & gas is leading to an increase in the requirement for highly-efficient...

Generative AI In Agriculture Market Overview: Extensive Evaluation of Market Size, Growth Opportunities

  The global   generative AI in agriculture market   size was estimated at USD 226.2 million in 2024 and is projected to reach USD 2,158.9 million by 2033, growing at a CAGR of 28.7% from 2025 to 2033. Farmers are increasingly using generative models to predict yields, weather impacts, and input requirements. This trend supports precision agriculture by enabling scenario-based planning. The global generative AI in agriculture industry is witnessing a shift toward AI-driven crop simulation and decision-making tools. The development of specialized, accessible, and efficient AI models for agricultural advisory, yield prediction, and climate adaptation is driving growth in the generative AI in agriculture market. This indicates growing demand for localized, multilingual, and climate-resilient advisory tools, especially for smallholder farmers in emerging regions, and signals a shift from general-purpose AI to frugal, scalable solutions suited for underserved agricul...

Solvent-Based Plastic Recycling Market | Analyzing State-of-the-Art Chemical Recovery Systems and Circular Economy Innovations Shaping Environmental Resilience

The global  solvent-based plastic recycling market  size is expected to reach USD 965.10 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 5.9% from 2022 to 2030. Growing consumption of plastics has resulted in growing plastic waste which because of improper plastic waste management has become a global crisis. Solvent-based recycling of plastic waste is one of the innovative ways to solve this crisis. To remove impurities a selective solvent dissolution process is used to recover plastics of minimum standards suitable for reuse.   Solvent-based Plastic Recycling Market Report Highlights The polystyrene product segment led the market with a revenue share of more than 47.7% in 2021 and is expected to maintain a healthy growth rate over the forecast period Stringent regulations regarding single-use plastic ban across regions including Europe, North America, and Asia, are expected to f...